The genetic mutation that causes Huntington's disease (HD)—a devastating brain disease that disrupts mobility and diminishes ...

Bayer has become the latest in a long line of drug developers to give up on Huntington’s disease after the German pharma ...

The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...

A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.

The show is a joint project by artists Bert and Elise Holland, Charlotte, Clair, Evie, Kate, Spencer James and Steven Hart.

Researchers uncover a link between impaired glutathione–ascorbate metabolism and early dopamine increases in Huntington's ...

Scientists have developed a novel polymer-based therapy that could slow Huntington's disease progression by preventing ...

Salim Syed’s rating is based on the positive regulatory feedback from the FDA regarding Wave Life Sciences’ lead candidate, WVE-003, for Huntington’s disease. The FDA’s openness to a pathway for ...

Breakthrough polymer-based therapy shows promise in reversing Huntington's disease symptoms by preventing toxic protein ...

In a report released yesterday, Madison Elsaadi from B.Riley Financial reiterated a Buy rating on Wave Life Sciences (WVE – Research ...

The discovery of an important enzyme involved in Huntington's disease may pave the way for future treatments to prevent the ...

Research in mice is hinting at a possible means of slowing or stopping the disease In a Huntington's mouse model, rodents ...